Author:
Moravcova Sarka,Kyle Bonnie,Shanahan Hilary,Giannaris Savvas,Smith Andrew,Hamilton-Davies Colin
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Allen KB, Fowler Jr VG, Gammie JS, et al. Staphylococcus aureus infections after elective cardiothoracic surgery: observations from an international randomized placebo-controlled trial of an investigational S. aureus vaccine. Open Forum Infect Dis. 2014;1(2):1–7.
2. Barclay GR. Bacterial endotoxins: lipopolysaccharides from genes to therapy. In: Levin J, Alving CR, Munford RS, Redl H, editors. Progress in clinical and biological research. New York: Wiley; 1995.
3. Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, et al. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA. 1997;277(8):646–50.
4. Colque-Navarro P, Soderquist B, Holmberg H, Blomqvist L, Olcen P, Mollby R. Antibody response in Staphylococcus aureus septicaemia—a prospective study. J Med Microbiol. 1998;47(3):217–25.
5. Coskun D, Aytac J, Aydinli A, Bayer A. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect. 2005;60(2):176–9.